ATOS — Atossa Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Atossa Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	12.6	39.6	136	111	88.5
Net Total Receivables	0.74	0.635	1.07	0.743	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	14.3	42.8	141	118	92.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.085	0.039	0.02	—	—
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	14.5	42.8	141	124	96.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.32	15.7	3.13	5.57	5.24
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.33	15.7	3.13	5.57	5.24
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	13.2	27.2	138	118	91
Total Liabilities & Shareholders' Equity	14.5	42.8	141	124	96.3
Total Common Shares Outstanding
Total Preferred Shares Outstanding